Answers are grounded in this paper and cite their sources.
Experimental study demonstrates automated carbon-11 carbonylation of aryl halides, suggesting a reliable route to synthesize benzamide radiotracers for molecular imaging.
The carbon‐11 ( 11 C) labeling of benzamides holds great promise in the development of PET radiotracers given the prevalence of benzamides in bioactive molecules. This work establishes an improved automated route to 11 C labeled primary benzamides through carbonylative cross‐coupling of aryl halides with 11 C carbon monoxide using electrophilic aroyl dimethylaminopyridinium salts as an intermediate. The methodology uses GE TRACERLab FX automated radiochemistry synthesis modules and allows for the synthesis of a variety of benzamide containing compounds, including known PET imaging agent [ 11 C]LY2795050, a KOR antagonist, in moderate to excellent radiochemical yields. This not only provides a practical means of synthesizing primary [ 11 C]benzamides, but it sets the stage for potential future applications in PET tracer synthesis. Overall, this development offers a versatile tool for generating 11 C‐labeled compounds for PET imaging applications thus, opening new avenues in the field of molecular imaging and advancing our understanding of various biological processes.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: